Skip to main content
. 2016 Dec 8;13(12):1216. doi: 10.3390/ijerph13121216

Table 1.

Saliva cotinine concentrations according to self-reported active and passive smoking status during pregnancy.

Tobacco Smoke Exposure * n Geometric Mean (ng/mL) 95% CI (ng/mL)
Non-smokers
 1st trimester (n = 1505; missing = 231) 1274 1.14 1.06–1.22
 2nd trimester (n = 1356; missing = 554) 802 1.10 1.01–2.00
 3rd trimester (n = 1273; missing = 293) 980 1.15 1.07–1.24
Smokers
 1st trimester (n = 196; missing = 39) 157 78.77 65.53–94.68
 2nd trimester (n = 142; missing = 36) 106 98.48 81.83–118.52
 3rd trimester (n = 122; missing = 23) 99 85.84 69.75–105.65
Passive smokers **
 1st trimester husband/partner smoking (n = 423; missing = 61) 362 1.84 1.56–2.16
 2nd trimester husband/partner smoking (n = 338; missing = 148) 190 2.08 1.66–2.60
 3rd trimester husband/partner smoking (n = 325; missing = 82) 243 1.89 1.55–2.31
 1st trimester ETS exposure (n = 614; missing = 99) 515 1.55 1.36–1.76
 2nd trimester ETS exposure (n = 236; missing = 106) 130 3.24 a 2.34–4.49
 3rd trimester ETS exposure (n = 204; missing = 65) 139 3.42 b 2.57–4.56
 1st trimester smoking allowed at home (n = 239; missing = 30) 209 2.86 2.27–3.61
 2nd trimester smoking allowed at home (n = 185; missing = 80) 105 3.53 2.51–4.96
 3rd trimester smoking allowed at home (n = 181; missing = 45) 136 3.19 2.37–4.28

a Environmental tobacco smoke (ETS) 1st trimester vs. ETS 2nd trimester, p < 0.001 (nonparametric Wilcoxon test); b ETS 1st trimester vs. ETS 3rd trimester, p < 0.001 (nonparametric Wilcoxon test); * the numbers might not sum up to the total sample size as some missing data were observed (described in the Materials and Methods section of the manuscript); ** restricted to non-smokers; CI: confidence interval.